Cooling moistening Decoction on narrow band UVB treatment of psoriasis vulgaris efficacy evaluation.docVIP

 PAGE \* MERGEFORMAT 9 Cooling moistening Decoction on narrow band UVB treatment of psoriasis vulgaris efficacy evaluation Study: Tsunami Zhou, Wu Gorge, Shuyou Lian, Li Guangrui, Zhang Qiang, Wang, Xu Chunyan [Keywords:] psoriasis, narrow band UVB, cooling soup Runzao Clinical Dermatology Psoriasis is a common chronic, relapsing, inflammatory skin diseases, application of cooling moistening Decoction author Narrow band UVB (NB-UVB) therapy to achieve better efficacy, are reported below. 1 Clinical data 1.1 Diagnosis and inclusion criteria Meet the lt;”Modern Dermatologygt;gt; [1] diagnostic criteria, age 18 to 65 years old, skin lesions area ofgt; 10% body surface area for total body irradiation were nearly no system within 1 month of topical application or corticosteroids, immune inhibitors and retinoic acid drugs, and informed consent. 1.2 Exclusion criteria Infection, pregnancy, childbirth, trauma, stress and other persons, nearly a month topical application or system corticosteroids and immunosuppressive agents who have photosensitivity diseases and severe heart, liver, kidney disease and mental illness. 1.3 General Information According to the inclusion and exclusion criteria, 120 patients were enrolled, all hospital outpatient dermatology patients with psoriasis vulgaris. By randomization divided into treatment group and control group Ⅰ, Ⅱ control group, 40 patients in each group. In which the treatment group 21 males and 19 females, mean age (35.55 + -12.15) years, mean disease duration (6.54 + -2.36), the lesion score before treatment (18.55 + -2.19) and the control group Ⅰ, 19 males and 21 females, mean age (37.00 ± 10.11) years, mean disease duration (7.01 + -3.13) years, before treatment lesion score (17.14 + -3.11) and the control group Ⅱ, 20 males and 20 females, mean age (34.18 + -8.15) years, mean disease duration (6.12 + -2.69), the lesion score before treatment (19.19 ± 2.56) sub-.3 group sex, age, disease dura